Current through Register Vol. 56, No. 21, November 4, 2024
Section 13:39-13.7 - Scope of collaborative drug therapy management(a) Collaborative drug therapy management shall be between a single patient with whom the physician has a bona fide physician-patient relationship, the physician, and the patient's collaborative practice pharmacist(s) and shall address that patient's specific condition, disease or diseases.(b) Collaborative drug therapy management may include the collecting, analyzing, and monitoring of patient data, ordering or performing of laboratory tests based on the standing orders of a physician as set forth in the written collaborative practice protocols, consistent with (c) below; ordering of clinical tests based on the standing orders of a physician as set forth in the written collaborative practice protocols; modifying, continuing, or discontinuing drug or device therapy; and therapeutic drug monitoring with appropriate modification to dose, dosage regimen, dosage forms, or route of administration.(c) A pharmacist may perform laboratory tests that are granted waived status in accordance with the provisions of the "New Jersey Clinical Laboratory Improvement Act," P.L. 1975, c. 166 (N.J.S.A. 45:9-42.26 et seq.), Department of Health's rules set forth at N.J.A.C. 8:44, and Department of Health CLIA Program requirements, available at http://www.state.nj.us/health/phel/instruct116.shtml [File Link Not Available], provided the tests are consistent with the pharmacy practice area or disease state covered by the collaborative practice agreement.(d) The interpretation of clinical or laboratory tests under a written collaborative practice protocol shall be performed by a pharmacist only in direct consultation with a physician.(e) Collaborative drug therapy management shall not include therapeutic interchange at the time of dispensing without the prior, specific informed consent of the patient and the consent of the patient's physician. Written confirmation of the consent, which may be by electronic means, shall be maintained at the pharmacy practice site of the collaborating pharmacist. N.J. Admin. Code § 13:39-13.7
Amended by 49 N.J.R. 3761(a), effective 12/4/2017